Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-lactamases: current situation and clinical importance

J Garau1

  • 1Hospital de Mutua de Terrassa, Barcelona, Spain.

Intensive Care Medicine
|July 1, 1994
PubMed
Summary

Bacterial resistance to beta-lactam antibiotics is primarily due to beta-lactamase enzymes. These enzymes, increasingly widespread, can neutralize many antibiotics, necessitating careful treatment choices based on bacterial resistance patterns.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Guidelines for the management of community pneumonia in adult who needs hospitalization].

Medicina intensiva·2024
Same author

Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen.

Journal of global antimicrobial resistance·2017
Same author

Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options.

Journal of global antimicrobial resistance·2016
Same author

Vancomycin in the treatment of meticillin-resistant Staphylococcus aureus (MRSA) infection: End of an era?

Journal of global antimicrobial resistance·2016
Same author

Per Migliorare la Guarigione di Pazienti Affetti da Infezione del Tratto Respiratorio.

Journal of chemotherapy (Florence, Italy)·2016
Same author

Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pharmacology

Background:

  • Bacterial resistance to beta-lactam antibiotics is a significant global health concern.
  • Beta-lactamase production is the primary mechanism of this resistance.
  • These enzymes hydrolyze beta-lactam antibiotics, rendering them ineffective.

Purpose of the Study:

  • To review the mechanisms and spread of beta-lactamase-mediated bacterial resistance.
  • To highlight the impact of extended-spectrum beta-lactamases (ESBLs) on antibiotic efficacy.
  • To emphasize the importance of understanding resistance patterns for effective therapeutic selection.

Main Methods:

  • Literature review of studies on beta-lactamase production and bacterial resistance.
  • Analysis of the spread of beta-lactamases across different bacterial genera.
  • Examination of the enzymatic activity of beta-lactamases against various beta-lactam antibiotics.

Main Results:

  • Plasmid-mediated beta-lactamases, initially in Enterobacteriaceae, have spread to other species like Pseudomonas aeruginosa.
  • Extended-spectrum beta-lactamases (ESBLs) confer resistance to cephalosporins and older beta-lactams.
  • Chromosomally mediated beta-lactamases can lead to resistance against nearly all beta-lactams, except carbapenems.

Conclusions:

  • Beta-lactamase production is a critical factor in bacterial resistance to beta-lactam antibiotics.
  • The increasing prevalence and spectrum of beta-lactamases necessitate careful antibiotic stewardship.
  • Therapeutic decisions must consider the specific resistance profiles of causative bacterial pathogens.

Related Experiment Videos